Literature DB >> 19474261

Antibodies specific for the Hia adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity.

Linda E Winter1, Stephen J Barenkamp.   

Abstract

The Hia autotransporter proteins are highly immunogenic surface adhesins expressed by nontypeable Haemophilus influenzae (NTHI). The objective of our study was to assess the opsonophagocytic activity of anti-Hia antibodies against homologous and heterologous NTHI. A segment of the hia gene that encodes a surface-exposed portion of the H. influenzae strain 11 Hia protein was cloned into a pGEMEX-2 expression vector. Escherichia coli JM101 was transformed with the resulting pGEMEX-Hia BstEII del recombinant plasmid, and recombinant fusion protein was recovered. An immune serum against recombinant GEMEX-Hia (rGEMEX-Hia)-mediated killing of the homologous NTHI strain 11 at a 1:160 titer and five heterologous Hia-expressing strains at titers of > or =1:40. Immune serum did not mediate killing of two Hia-knockout strains whose hia genes were inactivated but did mediate killing of one knockout strain at a high titer after the strain was transformed with a plasmid containing the hia gene. Immune serum did not mediate killing of HMW1/HMW2-expressing NTHI strains, which do not express the Hia adhesin. However, when two representative HMW1/HMW2-expressing strains were transformed with the plasmid containing the hia gene, they expressed abundant Hia and were susceptible to killing by the immune serum. Immune serum did not mediate killing of HMW1/HMW2-expressing strains transformed with the plasmid without the hia gene. Our results demonstrate that the Hia proteins of NTHI are targets of opsonophagocytic antibodies and that shared epitopes recognized by such antibodies are present on the Hia proteins of unrelated NTHI strains. These data argue for the continued investigation of the Hia proteins as vaccine candidates for the prevention of NTHI disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474261      PMCID: PMC2708409          DOI: 10.1128/CVI.00090-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

1.  The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children.

Authors:  Patricia Stutzmann Meier; Rolf Troller; Ioanna N Grivea; George A Syrogiannopoulos; Christoph Aebi
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  The Haemophilus influenzae Hia autotransporter contains an unusually short trimeric translocator domain.

Authors:  Neeraj K Surana; David Cutter; Stephen J Barenkamp; Joseph W St Geme
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

Review 3.  Haemophilus influenzae: genetic variability and natural selection to identify virulence factors.

Authors:  Janet R Gilsdorf; Carl F Marrs; Betsy Foxman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae.

Authors:  Xin-Xing Gu; Susan F Rudy; Chiayung Chu; Linda McCullagh; Hung N Kim; Jing Chen; Jianping Li; John B Robbins; Carter Van Waes; James F Battey
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.

Authors:  Lolita Piglansky; Eugene Leibovitz; Simon Raiz; David Greenberg; Joseph Press; Alberto Leiberman; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2003-05       Impact factor: 2.129

7.  Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Changes in frequency and pathogens causing acute otitis media in 1995-2003.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

9.  Structural basis for host recognition by the Haemophilus influenzae Hia autotransporter.

Authors:  Hye-Jeong Yeo; Shane E Cotter; Sven Laarmann; Twyla Juehne; Joseph W St Geme; Gabriel Waksman
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

10.  NadA, a novel vaccine candidate of Neisseria meningitidis.

Authors:  Maurizio Comanducci; Stefania Bambini; Brunella Brunelli; Jeannette Adu-Bobie; Beatrice Aricò; Barbara Capecchi; Marzia Monica Giuliani; Vega Masignani; Laura Santini; Silvana Savino; Dan M Granoff; Dominique A Caugant; Mariagrazia Pizza; Rino Rappuoli; Marirosa Mora
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  13 in total

1.  Selection and Counterselection of Hia Expression Reveals a Key Role for Phase-Variable Expression of Hia in Infection Caused by Nontypeable Haemophilus influenzae.

Authors:  John M Atack; Linda E Winter; Joseph A Jurcisek; Lauren O Bakaletz; Stephen J Barenkamp; Michael P Jennings
Journal:  J Infect Dis       Date:  2015-02-23       Impact factor: 5.226

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 3.  Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.

Authors:  Timothy F Murphy
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

4.  Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

5.  Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae.

Authors:  Laura A Novotny; Kenneth L Brockman; Elaine M Mokrzan; Joseph A Jurcisek; Lauren O Bakaletz
Journal:  J Pediatr Infect Dis       Date:  2018-07-06       Impact factor: 0.293

Review 6.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

7.  Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

8.  Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

9.  Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure.

Authors:  Matteo De Chiara; Derek Hood; Alessandro Muzzi; Derek J Pickard; Tim Perkins; Mariagrazia Pizza; Gordon Dougan; Rino Rappuoli; E Richard Moxon; Marco Soriani; Claudio Donati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

10.  Genomic Analysis of Pasteurella atlantica Provides Insight on Its Virulence Factors and Phylogeny and Highlights the Potential of Reverse Vaccinology in Aquaculture.

Authors:  Rebecca Marie Ellul; Panos G Kalatzis; Cyril Frantzen; Gyri Teien Haugland; Snorre Gulla; Duncan John Colquhoun; Mathias Middelboe; Heidrun Inger Wergeland; Anita Rønneseth
Journal:  Microorganisms       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.